LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pioneering Hospital Group to Build New Medical Center in Dubai

By LabMedica International staff writers
Posted on 24 Feb 2014
Saudi-based Dr. Soliman Fakeeh Hospital (DSFH; Jeddah, Saudi Arabia) has announced plans to build, at an estimated AED 1 billion, a university and hospital in Dubai (UAE) Silicon Oasis (DSO). DSFH is one of the largest private hospitals in the Middle East with a total bed capacity of 600. DSFH has been a leader that has helped advance by leaps the standards of healthcare delivery in the Saudi Arabia and in the region.

DSFH's project in Dubai is expected to boost medical tourism in the United Arab Emirates (UAE) while addressing the shortage of skilled healthcare staff in the region. Construction will be carried out in phases with the 300-bed hospital scheduled to be completed by 2017, and the medical university by 2019. Built across 150,000 square meters, the hospital university project is expected to offer 4,000 new jobs, according to DSFH.

“The initiative is also a step forward in the implementation of the strategy of the Executive office to make Dubai a hub for medical tourism,” said Dr. Mohammed Al Zarooni, vice chairman and the CEO of the DSO Authority. “Recent statistics show that the number of medical tourists receiving treatment is estimated to increase by 15% each year. Additionally, healthcare spending in the UAE is expected to reach AED 40 billion by 2015, while medical tourists are set to cross the 20 million mark for the same period.” Also, a recent Ernst & Young report on the Gulf Cooperation Council (GCC) countries' healthcare industry called for more skilled local professionals to reduce reliance on expatriate staff, and noted that the region’s healthcare industry is seeing a rise in the number of private investors.

The new hospital, offering secondary and tertiary medical service, will mainly target the growing residence community in DSO and neighboring areas. The 300-bed facility is expected to cater to around 700,000 patients a year, with an estimated 40,000 admissions and 20,000 surgical operations.

Fakeeh Medical University (FMU), which will be built alongside the hospital, will offer instructions in fields such as medicine, nursing, laboratory sciences, radiology, physiotherapy, dentistry, clinical pharmacy, and health policy and management. The project will also include a basic sciences research and development center to develop innovations in the medical field. To encourage collaboration between medical professionals, FMU will partner with local universities, including the Rochester Institute of Technology in DSO; American University of Sharjah; Al Ain University and Dubai Academic City.

“This project will certainly tick all the boxes through value health treatments, best medical advice, job creation, and most importantly the creation of a dependable knowledge in the health field that will benefit this region,” said Dr. Al Zarooni.

Related Links:

Dr. Soliman Fakeeh Hospital

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more